Chromosome 9p24.1/PD-L1/PD-L2Alterations and PD-L1 Expression and Treatment Outcomes in Patients with Classical Hodgkin Lymphoma Treated with Nivolumab (PD-1 Blockade)

被引：8

作者：

Roemer, Margaretha G. M. ^{[1
]}

Ligon, Azra H. ^{[2
]}

Engert, Andreas ^{[3
,4
]}

Younes, Anas ^{[5
]}

Santoro, Armando ^{[6
,7
]}

Zinzani, Pier Luigi ^{[8
]}

Timmerman, John M. ^{[9
]}

Ansell, Stephen ^{[10
]}

Armand, Philippe ^{[11
,12
]}

Fanale, Michelle A. ^{[13
]}

Ratanatharathorn, Voravit ^{[14
]}

Kuruvilla, John ^{[15
]}

Cohen, Jonathon B. ^{[16
]}

Collins, Graham P. ^{[17
]}

Savage, Kerry J. ^{[18
,19
]}

Trneny, Marek ^{[20
,21
]}

Neuberg, Donna S. ^{[22
]}

Redd, Robert A. ^{[23
]}

Farsaci, Benedetto ^{[24
]}

Kato, Kazunobu ^{[24
]}

Sumbul, Anne ^{[24
]}

Rodig, Scott J. ^{[25
]}

Shipp, Margaret A. ^{[26
]}

机构：

[1] Dana Farber Canc Inst, Med Oncol, Boston, MA USA

[2] Brigham & Womens Hosp, Pathol, Boston, MA USA

[3] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany

[4] Univ Hosp Cologne, GHSG, Cologne, Germany

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY USA

[6] Humanitas Univ, Milan, Italy

[7] Humanitas Res Hosp, Milan, Italy

[8] Univ Bologna, Inst Hematol L & A Seragnoli, Bologna, Italy

[9] UCLA Med Ctr, Los Angeles, CA USA

[10] Mayo Clin, Rochester, MN USA

[11] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA USA

[12] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA

[13] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA

[14] Barbara Ann Karmanos Canc Inst, Detroit, MI USA

[15] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada

[16] Emory Univ, Winship Canc Inst, Atlanta, GA USA

[17] Churchill Hosp, Oxford Canc & Haematol Ctr, Oxford, England

[18] British Columbia Canc Agcy, Div Med Oncol, Vancouver, BC, Canada

[19] British Columbia Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada

[20] Charles Univ Prague, Dept Med 1, Prague, Czech Republic

[21] Gen Univ, Dept Med 1, Prague, Czech Republic

[22] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA USA

[23] Dana Farber Canc Inst, Biostat & Computat Biol, Boston, MA USA

[24] Bristol Myers Squibb, Princeton, NJ USA

[25] Dana Farber Harvard Canc Ctr, Dept Pathol, Boston, MA USA

[26] Dana Farber Canc Inst, Boston, MA USA

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.2923.2923

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2923

引用

页数：7

共 50 条

[21] Changes in PD-1 and PD-L1 Expression in Cases with Hodgkin Lymphoma after Chemotherapy
Paydas, Semra
Bagir, Emine
Ergin, Melek
Seydaoglu, Gulsah
BLOOD, 2015, 126 (23)
[22] PD-1/PD-L1 inhibitors
Sunshine, Joel
Taube, Janis M.
CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
[23] PD-1/PD-L1 in disease
Kuol, Nyanbol
Stojanovska, Lily
Nurgali, Kulmira
Apostolopoulos, Vasso
IMMUNOTHERAPY, 2018, 10 (02) : 149 - 161
[24] PD-1, PD-L1 and PD-L2 Expression in Mantle Cell Lymphoma and Healthy Population
Karolova, J.
Radek, M.
Helman, K.
Spacek, M.
Trneny, M.
Klener, P.
FOLIA BIOLOGICA, 2020, 66 (04) : 117 - 122
[25] PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
Yaghoubi, Neda
Soltani, Arash
Ghazvini, Kiarash
Hassanian, Seyed Mahdi
Hashemy, Seyed Isaac
BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 312 - 318
[26] PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Roemer, Margaretha G. M.
Advani, Ranjana H.
Ligon, Azra H.
Natkunam, Yasodha
Redd, Robert A.
Homer, Heather
Connelly, Courtney F.
Sun, Heather H.
Daadi, Sarah E.
Freeman, Gordon J.
Armand, Philippe
Chapuy, Bjoern
de Jong, Daphne
Hoppe, Richard T.
Neuberg, Donna S.
Rodig, Scott J.
Shipp, Margaret A.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (23) : 2690 - +
[27] PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Hamanishi, Junzo
Mandai, Masaki
Matsumura, Noriomi
Abiko, Kaoru
Baba, Tsukasa
Konishi, Ikuo
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (03) : 462 - 473
[28] PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Junzo Hamanishi
Masaki Mandai
Noriomi Matsumura
Kaoru Abiko
Tsukasa Baba
Ikuo Konishi
International Journal of Clinical Oncology, 2016, 21 : 462 - 473
[29] PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Roemer, Margaretha G. M.
Advani, Ranjana H.
Ligon, Azra H.
Natkunam, Yasodha
Redd, Robert A.
Homer, Heather
Connelly, Courtney
Sun, Heather H.
Daadi, Sarah E.
Chapuy, Bjoern
de Jong, Daphne
Hoppe, Richard T.
Neuberg, Donna S.
Rodig, Scott J.
Shipp, Margaret A.
BLOOD, 2015, 126 (23)
[30] Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
Dimitrios Mathios
Jacob Ruzevick
Christopher M. Jackson
Haiying Xu
Sagar R. Shah
Janis M. Taube
Peter C. Burger
Edward F. McCarthy
Alfredo Quinones-Hinojosa
Drew M. Pardoll
Michael Lim
Journal of Neuro-Oncology, 2016, 128 : 183 - 183

← 1 2 3 4 5 →